AAAAAA

   
Results: 1-12 |
Results: 12
Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells
Authors: Iqbal, M Davies, MPA Shoker, BS Jarvis, C Sibson, DR Sloane, JP
Citation: M. Iqbal et al., Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells, J PATHOLOGY, 193(3), 2001, pp. 333-338
Immunodetectable cyclin D-1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
Authors: Shoker, BS Jarvis, C Davies, MPA Iqbal, M Sibson, DR Sloane, JP
Citation: Bs. Shoker et al., Immunodetectable cyclin D-1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions, BR J CANC, 84(8), 2001, pp. 1064-1069
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer
Authors: Brown, J Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Hayes, C Jenkins, JPR Leach, MO Moss, SM Padhani, AP Pointon, LJ Ponder, BAJ Sloane, JP Turnbull, LW Walker, LG Warren, RML Watson, W
Citation: J. Brown et al., Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 72-77
Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer
Authors: Brown, J Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Hayes, C Jenkins, JPR Leach, MO Moss, SM Padhani, AP Pointon, LJ Ponder, BAJ Sloane, JP Turnbull, LW Walker, LG Warren, RML Watson, W
Citation: J. Brown et al., Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 78-82
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast
Authors: Elston, CW Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Dervan, P Drijkoningen, M Eusebi, V Faverly, D Holland, R Jacquemier, J Lacerda, M Martinez-Penuela, J de Miguel, C Moss, S Munt, C Peterse, JL Rank, F Reiner, A Sylvan, M Wells, CA Zafrani, B
Citation: Cw. Elston et al., Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast, EUR J CANC, 36(14), 2000, pp. 1769-1772
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study
Authors: Brown, J Buckley, D Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Graves, M Hayes, C Jenkins, JPR Jones, AP Keevil, SF Leach, MO Liney, GP Moss, SM Padhani, AR Parker, GJM Pointon, LJ Ponder, BAJ Redpath, TW Sloane, JP Turnbull, LW Walker, LG Warren, RML
Citation: J. Brown et al., Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study, MAGN RES IM, 18(7), 2000, pp. 765-776
Abnormal regulation of the oestrogen receptor in benign breast lesions
Authors: Shoker, BS Jarvis, C Clarke, RB Anderson, E Munro, C Davies, MPA Sibson, DR Sloane, JP
Citation: Bs. Shoker et al., Abnormal regulation of the oestrogen receptor in benign breast lesions, J CLIN PATH, 53(10), 2000, pp. 778-783
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas
Authors: Sloane, JP Amendoeira, I Apostolikas, N Bellocq, JP Bianchi, S Boecker, W Bussolati, G Coleman, D Connolly, CE Eusebi, V De Miguel, C Dervan, P Drijkoningen, R Elston, CW Faverly, D Gad, A Jacquemier, J Lacerda, M Martinez-Penuela, J Munt, C Peterse, JL Rank, F Sylvan, M Tsakraklides, V Zafrani, B
Citation: Jp. Sloane et al., Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas, VIRCHOWS AR, 434(1), 1999, pp. 3-10
DCIS grading schemes and clinical implications
Authors: Shoker, BS Sloane, JP
Citation: Bs. Shoker et Jp. Sloane, DCIS grading schemes and clinical implications, HISTOPATHOL, 35(5), 1999, pp. 393-400
Oestrogen receptor expression in the normal and pre-cancerous breast
Authors: Shoker, BS Jarvis, C Sibson, DR Walker, C Sloane, JP
Citation: Bs. Shoker et al., Oestrogen receptor expression in the normal and pre-cancerous breast, J PATHOLOGY, 188(3), 1999, pp. 237-244
Estrogen receptor-positive proliferating cells in the normal and precancerous breast
Authors: Shoker, BS Jarvis, C Clarke, RB Anderson, E Hewlett, J Davies, MPA Sibson, DR Sloane, JP
Citation: Bs. Shoker et al., Estrogen receptor-positive proliferating cells in the normal and precancerous breast, AM J PATH, 155(6), 1999, pp. 1811-1815
Risultati: 1-12 |